Sign in

CIK 0001708527

  • Non-accelerated filer
  • Smaller reporting company

ELUTIA INC.

Sign in to watch
Ticker
ELUT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474790334
Phone
+1 240-247-1143
Business address
12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD, 20904
Former names
AZIYO BIOLOGICS, INC.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Option exercise PRESIDENT AND CEO acquired 44,947 shares (option exercise)
  4. 4 Open-market buy 10% owner bought 140,000 shares at an average $1.48 ($206,958)
  5. 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 289 shares at $4.30 ($1,243)
  6. 4 Option exercise CHIEF FINANCIAL OFFICER acquired 1,287 shares (option exercise)
  7. 4 Open-market buy 10% owner bought 97,261 shares at an average $4.09 ($398,230)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Director bought 3,098 shares at $3.90 ($12,082)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market buy Director bought 2,000 shares at $3.65 ($7,300)
  14. 4 Open-market buy Director bought 735,000 shares at $4.75 ($3,491,250)
  15. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 28,000 shares at an average $4.51 ($126,400)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 4,798 shares (to pay taxes)
  20. 4 Shares withheld for taxes GENERAL COUNSEL gave up 1,127 shares (to pay taxes)

Page 6 of 9 · 170 filings